Dietary exposure to whey proteins alters rat mammary gland proliferation, apoptosis, and gene expression during postnatal development

Journal of Nutrition

Volumn 134, Issue 12, 2004, Pages 3370-3377

  Eason, Renea R ^a   Velarde, Michael C ^a,b   Chatman Jr , Leon ^a   Till, S Reneé ^a   Geng, Yan ^a,b   Ferguson, Matthew ^a   Badger, Thomas M ^a,b   Simmen, Rosalia C M ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cancer; Development; Mammary gland; PTEN; Whey proteins

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BETA CASEIN; CYCLINE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; CANCER INCIDENCE; CANCER PREVENTION; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNOREACTIVITY; NICK END LABELING; NONHUMAN; POSTNATAL DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INTAKE; RAT; TUMOR SUPPRESSOR GENE; WHEY;

ANIMALIA;

EID: 10044243889     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.12.3370     Document Type: Article

References (49)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. & Thun, M. J. (2003) Cancer statistics, 2003. CA. Cancer J. Clin. 53: 5-26.
2. Barker, D.J.P. (1997) Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 13: 807-813.
3. Shu, X. O., Jin, F., Dai, Q., Wen, W., Potter, J. D., Kushi, L. H., Ruan, Z., Gao, Y. T. & Zheng, W. (2001) Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev. 10: 483-488.
4. Wu, A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C. & Pike, M. C. (2002) Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 23: 1491-1496.
5. Peeters, P. H., Keinan-Boker, L., van der Schouw, Y. T. & Grobbee, D. E. (2003) Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res. Treat. 77: 171-183.
6. Ziegler, R. G. (2004) Phytoestrogens and breast cancer. Am. J. Clin. Nutr. 79: 183-184.
7. Hawrylewicz, E. J., Huang, H. H. & Blair, W. H. (1991) Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J. Nutr. 121: 1693-1698.
8. Fritz, W. A., Coward, L., Wang, J. & Lamartiniere, C. A. (1998) Dietary genistein: perinatal mammary cancer protection, bioavailability and toxicity testing in the rat. Carcinogenesis 19: 2151-2158.
9. Hakkak, R., Korourian, S., Shelnutt, S. R., Lensing, S., Ronis, M.J.J. & Badger, T. M. (2000) Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol. Biomarkers Prev. 9: 113-117.
10. Rowlands, J. C., He, L., Hakkak, R., Ronis, M. J. & Badger, T. M. (2001) Soy and whey proteins downregulate DMBA-induced liver and mammary gland CYP1 expression in female rats. J. Nutr. 131: 3281-3287.
11. Rowlands, J. C., Hakkak, R., Ronis, M.J.J. & Badger, T. M. (2002) Altered mammary gland differentiation and progesterone receptor expression in rats fed soy and whey proteins. Toxicol. Sci. 70: 40-45.
12. Russo, J. & Russo, I. H. (1980) Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res. 40: 2677-2687.
13. Li, Y., Upadhyay, S., Bhuiyan, M. & Sarkar, F. H. (1999) Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18: 3166-3172.
14. Lu, L.-J.W., Anderson, K. E., Grady, J. J., Kohen, F. & Nagamani, M. (2000) Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 60: 4112-4121.
15. Gallo, D., Giacomelli, S., Cantelmo, F., Zannoni, G. F., Ferrandina, G., Fruscella, E., Riva, A., Morazzoni, P., Bombardellli, E., Mancuso, S. & Scambia, G. (2001) Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy. Breast Cancer Res. Treat. 69: 153-164.
16. Lamartiniere, C. A. (2000) Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr. 71 (suppl. 6): 1705S-1707S.
17. Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P. & Mak, T. W. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
18. Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A. & Sugimoto, C. (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998.
19. Weng, L.-P., Brown, J. L., Baker, K. M., Ostrowski, M. C. & Eng, C. (2002) PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum. Mol. Genet. 11: 1687-1696.
20. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H. & Parsons, R. (1997) PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947.
21. Stambolic, V., Tsao, M. S., Macpherson, D., Suzuki, A., Chapman, W. B. & Mak, T. W. (2000) High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/-mice. Cancer Res. 60: 3605-3611.
22. Perren, A., Weng, L. P., Boag, A. H., Ziebold, U., Thakore, K., Dahia, P. L., Komminoth, P., Lees, J. A., Mulligan, L. M., Mutter, G. L. & Eng, C. (1999) Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol. 155: 1253-1260.
23. Depowski, P. L., Rosenthal, S. I. & Ross, J. S. (2001) Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod. Pathol. 14: 672-676.
24. Li, G., Robinson, G. W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.-U., Wu, D.-C., Lane, T. F., Liu, X., Hennighausen, L. & Wu, H. (2002) Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129: 4159-4170.
25. Dupont, J., Renou, J. P., Shani, M., Hennighausen, L. & LeRoith, D. (2002) PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J. Clin. Invest. 110: 815-825.
26. Ha, E. & Zemel, M. B. (2003) Functional properties of whey, whey components, and essential amino acids: mechanisms underlying health benefits for active people. J. Nutr. Biochem. 14: 251-258.
27. Reeves, P. G., Nielsen, F. H. & Fahey, G. C., Jr. (1993) AIN93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939-1951.
28. Dulbecco, R., Henahan, M. & Armstrong, B. (1982) Cell types and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 79: 7346-7350.
29. Lydon, J. P., Ge, G., Kittrell, F. S., Medina, D. & O'Malley, B. W. (1999) Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59: 4276-4284.
30. Radu, A., Neubauer, V., Akagi, T., Hanafusa, H. & Georgescu, M.-M. (2003) PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol. Cell. Biol. 23: 6139-6149.
31. Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J. & Conneely, O. M. (2003) Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc. Natl. Acad. Sci. U.S.A. 100: 9744-9749.
32. Hennighausen, L. & Robinson, G. W. (2001) Signaling pathways in mammary gland development. Dev. Cell 1: 467-475.
33. Neville, M. C., McFadden, T. B. and Forsyth, I. (2002) Hormonal regulation of mammary differentiation and milk secretion. J. Mammary Gland Biol. Neoplasia 7: 49-66.
34. Moorehead, R. A., Hojilla, C. V., De Belle, I., Wood, G. A., Fata, J. E., Adamson, E. D., Watson, K.L.M., Edwards, D. R. & Khokha, R. (2003) Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J. Biol. Chem. 278: 50422-50427.
35. Humphreys, R. C. (1999) Programmed cell death in the terminal end bud. J. Mammary Gland Biol. Neoplasia 4: 213-220.
36. Aubele, M., Auer, G., Braselmann, H., Nahrig, J., Zitzelsberger, H., Quintanilla-Martinez, L., Smida, J., Walch, A., Hofler, H. & Werner, M. (2002) Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal. Cell Pathol. 24: 77-87.
37. Miller, B. J., Wang, D., Krahe, R. & Wright, F. A. (2003) Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am. J. Hum. Genet. 73: 748-767.
38. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100: 3983-3988.
39. Li, Y., Welm, B., Podsypanina, K., Huang, S., Chamorro, M., Zhang, X., Rowlands, T., Egeblad, M., Cowin, P., Werb, Z., Tan, L. K., Rosen, J. M. & Varmus, H. E. (2003) Evidence that transgenes encoding components of the Wnt signaling pathways preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 100: 15853-15858.
40. pos cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245: 42-56.
41. Guzeloglu-Kayisli, O., Kayisli, U. A., Al-Rejjal, R., Zheng, W., Luleci, G. & Arici, A. (2003) Regulation of PTEN (phosphatase and tensin homolog deleted in chromosome 10) expression by estradiol and progesterone in human endometrium. J. Clin. Endocrinol. Metab. 88: 5017-5026.
42. Kimura, F., Watanabe, J., Hata, H., Fujisawa, T., Kamata, Y., Nishimura, Y., Jobo, T. & Kuramoto, H. (2004) PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus. J. Cancer Res. Clin. Oncol. 130: 161-168.
43. Nicholson, K. M., Streuli, C. H. & Anderson, N. G. (2003) Autocrine signalling through erbB receptors promotes constitutive activation of protein kinaseB/Akt in breast cancer cell lines. Breast Cancer Res. Treat. 81: 117-128.
44. Hortobagyi, G. N., Hung, M.-C. & Buzdar, A. U. (1999) Recent developments in breast cancer therapy. Semin. Oncol. 26 (suppl. 12): 11-20.
45. Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J. & Kumar, R. (1998) Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase. J. Biol. Chem. 273: 28238-28246.
46. Pianetti, S., Arsura M., Romieu-Mourez, R., Coffey, R. J. & Sonenshein, G. E. (2001) Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene 20: 1287-1299.
47. Gu, J., Tamura, M. & Yamada, K. M. (1998) Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J. Cell Biol. 143: 1375-1383.
48. Bianco, R., Shin, I., Ritter, C. A., Yakes, F. M., Basso, A., Rosen, N., Tsurutani, J., Dennis, P. A., Mills, G. B. & Arteaga, C. L. (2003) Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene 22: 2812-2822.
49. She, Q. B., Solit, D., Basso, A. & Moasser, M. M. (2003) Resistance to gefinitib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. Clin. Cancer Res. 9: 4340-4346.